Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Multi-centric Castleman's Disease × Methotrexate × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 51 Burkitt Lymphoma 26 Leukemia, Myeloid, Acute 14 Leukemia, Biphenotypic, Acute 12 Myelodysplastic Syndromes 11 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia 9 Lymphoma, Mantle-Cell 6 Lymphoma 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5 Osteosarcoma 5 Medulloblastoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myeloid, Accelerated Phase 5 Blast Crisis 5 Recurrence 4 Hematologic Neoplasms 4 Graft vs Host Disease 4 Urinary Bladder Neoplasms 3 Primary Myelofibrosis 3 Neoplasm Metastasis 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Juvenile 3 Blastic Plasmacytoid Dendritic Cell Neoplasm 3 Thrombocythemia, Essential 2 Rhabdoid Tumor 2 Polycythemia Vera 2 Neoplasm, Residual 2 Myelodysplastic-Myeloproliferative Diseases 2

Interventions

liposomal doxorubicin 2 pomalidomide 1 Zidovudine 1 Vincristine 1 Valganciclovir 1 Sirolimus 1 Rituximab 1 Prednisone 1 Interferon-alpha 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Cyclophosphamide 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡